By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cognition Therapeutics Inc. 

2403 Sidney Street
Suite 261
Pittsburgh  Pennsylvania  15203  U.S.A.
Phone: 412-481-2210 Fax: 412-481-2216



Company News
Cognition Therapeutics Inc. Receives Michael J. Fox Foundation Grant To Study Inhibitors Of Alpha-Synuclein Oligomers For The Treatment Of Parkinson's Disease 9/29/2016 11:27:29 AM
Cognition Therapeutics Inc. Completes Oversubscribed $12 Million Series B Financing 9/8/2015 12:37:03 PM
Cognition Therapeutics Inc.Announces Publication Of Research Identifying Sigma-2/PGRMC1 Receptor As A Major New Drug Target For Alzheimer's Disease Therapy 11/13/2014 7:37:52 AM
Cognition Therapeutics Inc.'s Small Molecule Soluble Abeta Oligomer Receptor Antagonist Program For Alzheimer's Disease Selected For Support By National Institute on Aging/National Institutes of Health (NIH) Cooperative Agreement Program 5/22/2014 9:23:04 AM
Cognition Therapeutics Inc. Completes $2.5M in Series A1 Financing to Advance Alzheimer's Disease Drug Treatment Program 1/20/2011 6:37:54 AM
Alzheimer's Drug Discovery Foundation Funds Cognition Therapeutics Inc. to Advance Disease-Modifying Small Molecule Drug Candidates for Alzheimer's Disease 8/18/2010 8:38:19 AM
Cognition Therapeutics Inc. Closes Series A Financing to Advance Drug Candidates for Alzheimer's Disease 7/16/2009 6:45:39 AM